Observational Study
Copyright ©The Author(s) 2017.
World J Gastrointest Pharmacol Ther. Feb 6, 2017; 8(1): 67-73
Published online Feb 6, 2017. doi: 10.4292/wjgpt.v8.i1.67
Table 1 Respondents’ demographics, self-reported expertise and scope of inflammatory bowel disease practice
FrequencyPercentage
SexMale4647%
Female5253%
Age, yr20-2977%
30-444546%
45-604041%
> 6066%
Years in practice, yr< 51111%
5-92122%
10-141717%
15-191010%
≥ 203940%
ProfessionGastroenterology trainee1717%
Gastroenterology consultant5152%
IBD nurse specialist2829%
Other22%
Geographic regionEngland9295%
Scotland22%
Wales22%
Northern Ireland11%
Self-rated level of IBD interest in medically qualified staffGeneral gastroenterologist3246%
Interest in IBD1827%
Expert IBD physician1827%
IBD patients per weekRange 0-150
Mean 25
Table 2 Estimation of non-adherence levels by respondents and percentage in line with evidence
MedicationColumn A: literature-based non-adherence levelsColumn B: perceived mean non-adherence levelsProportion who estimated non-adherence levels below the levels in column A
Mesalazine30%-45%20%31%
Immunomodulator therapy15%-20%10%28%
Biological agents5%-10%1%23%
Table 3 Association between perception of non-adherence as a frequent problem and reporting non-adherence levels in line with the evidence base
Medicationχ2 valueDegrees of freedomP value
Mesalazine33.22610.000
Immunomodulator therapy12.59220.002
Biological agents7.45910.006
Table 4 Association between level of interest in inflammatory bowel disease and estimation of non-adherence to biological therapy
Pearsonχ2 testWhat percentage of your patients on biological therapy are non-adherent?
Level of interest in IBD for medical staffχ2 value8.863
Degrees of freedom2.000
P value0.012
Table 5 Perception of reasons for non-adherence
RankActual side effects of medicationPatient forgets to take medicationBenefits of medication not immediately apparentAnxiety or depressionPoor patient knowledge of diseaseFrequency of dosingBeliefs about necessity of medicationConcerns over potential side effects
Ranked 1st14.60%32.30%13.70%5.30%7.30%9.60%12.40%11.30%
Ranked 2nd9.40%25%20%7.40%11.50%18.10%23.70%14.40%
Ranked 3rd7.30%11.50%18.90%8.40%8.30%21.30%20.60%23.70%
Ranked 4th14.60%7.30%11.60%7.40%18.80%11.70%15.50%12.40%
Ranked 5th10.40%12.50%16.80%13.70%14.60%9.60%10.30%16.50%
Ranked 6th24%3.10%9.50%16.80%18.80%13.80%8.20%9.30%
Ranked 7th10.40%4.20%5.30%16.80%14.60%8.50%3.10%9.30%
Ranked 8th9.40%4.20%4.20%24.20%6.30%7.40%6.20%3.10%
Ranked in top 3 by n =3066502026465548
Overall rank61387524